The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
Alzheimer’s disease, a neurodegenerative disease, is one of the most common causes of dementia if elderly people worldwide. Alzheimer’s disease leads to the alienation of individuals and their exclusion from social and professional life. It is characterized mainly by the degradation of memory and di...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f40958322a24feda238eb1d1f4fc7c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8f40958322a24feda238eb1d1f4fc7c6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8f40958322a24feda238eb1d1f4fc7c62021-11-04T05:02:57ZThe Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease1663-981210.3389/fphar.2021.775034https://doaj.org/article/8f40958322a24feda238eb1d1f4fc7c62021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.775034/fullhttps://doaj.org/toc/1663-9812Alzheimer’s disease, a neurodegenerative disease, is one of the most common causes of dementia if elderly people worldwide. Alzheimer’s disease leads to the alienation of individuals and their exclusion from social and professional life. It is characterized mainly by the degradation of memory and disorientation, which occurs as a result of the loss of neuronal structure and function in different brain areas. In recent years, more and more attention has been paid to use in the treatment of natural bioactive compounds that will be effective in neurodegenerative diseases, including Alzheimer’s disease. G. biloba L. and its most frequently used standardized extract (EGb 761), have been used for many years in supportive therapy and in the prevention of cognitive disorders. The paper presents an overview of reports on the pathogenesis of Alzheimer’s disease, as well as a summary of the properties of G. biloba extract and its effects on the possible pathogenesis of the disease. By exploring more about the pathogenesis of the disease and the benefits of G. biloba extract for patients with Alzheimer’s disease, it will be possible to create an individualized therapeutic protocol to optimize the treatment.Anna NowakKlaudyna KojderJoanna Zielonka-BrzezickaJacek WróbelMateusz BosiackiMarta FabiańskaMariola WróbelJoanna Sołek-PastuszkaAdam KlimowiczFrontiers Media S.A.articleGinkgo biloba L.Alzheheimer’s diseaseneurodegenarative diseaseEGb 761 extractdementiaTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ginkgo biloba L. Alzheheimer’s disease neurodegenarative disease EGb 761 extract dementia Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Ginkgo biloba L. Alzheheimer’s disease neurodegenarative disease EGb 761 extract dementia Therapeutics. Pharmacology RM1-950 Anna Nowak Klaudyna Kojder Joanna Zielonka-Brzezicka Jacek Wróbel Mateusz Bosiacki Marta Fabiańska Mariola Wróbel Joanna Sołek-Pastuszka Adam Klimowicz The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
description |
Alzheimer’s disease, a neurodegenerative disease, is one of the most common causes of dementia if elderly people worldwide. Alzheimer’s disease leads to the alienation of individuals and their exclusion from social and professional life. It is characterized mainly by the degradation of memory and disorientation, which occurs as a result of the loss of neuronal structure and function in different brain areas. In recent years, more and more attention has been paid to use in the treatment of natural bioactive compounds that will be effective in neurodegenerative diseases, including Alzheimer’s disease. G. biloba L. and its most frequently used standardized extract (EGb 761), have been used for many years in supportive therapy and in the prevention of cognitive disorders. The paper presents an overview of reports on the pathogenesis of Alzheimer’s disease, as well as a summary of the properties of G. biloba extract and its effects on the possible pathogenesis of the disease. By exploring more about the pathogenesis of the disease and the benefits of G. biloba extract for patients with Alzheimer’s disease, it will be possible to create an individualized therapeutic protocol to optimize the treatment. |
format |
article |
author |
Anna Nowak Klaudyna Kojder Joanna Zielonka-Brzezicka Jacek Wróbel Mateusz Bosiacki Marta Fabiańska Mariola Wróbel Joanna Sołek-Pastuszka Adam Klimowicz |
author_facet |
Anna Nowak Klaudyna Kojder Joanna Zielonka-Brzezicka Jacek Wróbel Mateusz Bosiacki Marta Fabiańska Mariola Wróbel Joanna Sołek-Pastuszka Adam Klimowicz |
author_sort |
Anna Nowak |
title |
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
title_short |
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
title_full |
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
title_fullStr |
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
title_full_unstemmed |
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
title_sort |
use of ginkgo biloba l. as a neuroprotective agent in the alzheimer’s disease |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/8f40958322a24feda238eb1d1f4fc7c6 |
work_keys_str_mv |
AT annanowak theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT klaudynakojder theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT joannazielonkabrzezicka theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT jacekwrobel theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT mateuszbosiacki theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT martafabianska theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT mariolawrobel theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT joannasołekpastuszka theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT adamklimowicz theuseofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT annanowak useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT klaudynakojder useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT joannazielonkabrzezicka useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT jacekwrobel useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT mateuszbosiacki useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT martafabianska useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT mariolawrobel useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT joannasołekpastuszka useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease AT adamklimowicz useofginkgobilobalasaneuroprotectiveagentinthealzheimersdisease |
_version_ |
1718445225216573440 |